Organization | Clinical Research Management, Inc.

Clinical Research Management, Inc. Report issue

For profit Phase 2

Founded: Agawam MA United States (2000)

Status: Acquired by ICON (2016)

Organization Overview

First Clinical Trial

2015

NCT02380625

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Clinical Research Management, Inc.

Active Ingredients

Drugs in Phase 2 Trials (9)

atorvastatin (lipitor) (1 trial)

azithromycin (zithromax) (1 trial)

citric acid (1 trial)

erlotinib (tarceva) (1 trial)

gpi-0100 (1 trial)

irbesartan (avapro) (1 trial)

lactic acid (1 trial)

potassium hydrotartrate (1 trial)

sunitinib (sutent) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Chlamydia Infections (Phase 2)

Hemorrhagic Fever, Ebola (Phase 2)

Infections (Phase 2)

Squamous Intraepithelial Lesions of the Cervix (Phase 2)

Virus Diseases (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 3
# of Trial APIs: 9